NLVP
New Leaf Venture Partners Portfolio holdings
AUM
$52.9M
This Quarter Return
-18.83%
1 Year Return
-33.65%
3 Year Return
+15.24%
5 Year Return
+39.89%
10 Year Return
+615.06%
AUM
$82.2M
AUM Growth
+$82.2M
(-28%)
Cap. Flow
-$8.38M
Cap. Flow
% of AUM
-10.19%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
11
New
–
Increased
2
Reduced
–
Closed
1
Top Buys
| 1 |
Rocket Pharmaceuticals
RCKT
|
$699K |
| 2 |
Iterum Therapeutics
ITRM
|
$2 |
Top Sells
| 1 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
$9.08M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Arvinas
ARVN
$568M
| $34.3M | 41.74% | 1,289,521 | – | – |
|
2
Edgewise Therapeutics
EWTX
$1.51B
| $28M | 34.03% | 1,553,661 | – | – |
|
3
Crinetics Pharmaceuticals
CRNX
$2.92B
| $6.32M | 7.68% | 141,000 | – | – |
|
4
Rallybio
RLYB
$22.4M
| $4.42M | 5.38% | 3,301,603 | – | – |
|
|
5
Rocket Pharmaceuticals
RCKT
$354M
| $3.24M | 3.95% | 150,706 +32,464 | +27% | +$699K |
|
6
Cogent Biosciences
COGT
$1.69B
| $2.11M | 2.57% | 250,765 | – | – |
|
7
Passage Bio
PASG
$22.7M
| $1.98M | 2.41% | 2,497,922 | – | – |
|
8
Alector
ALEC
$238M
| $1.54M | 1.87% | 339,569 | – | – |
|
9
X4 Pharmaceuticals
XFOR
$84.2M
| $194K | 0.24% | 335,000 | – | – |
|
|
10
Iterum Therapeutics
ITRM
$30.2M
| $111K | 0.14% | 97,086 +2 | +0% | +$2 |
|
|
DCPH
11
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| – | – | -576,975 | Closed | -$9.08M |
|